Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PROX1 | hg19_v2_chr1_+_214161272_214161322 | -0.17 | 3.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_+_22180536 Show fit | 4.91 |
ENST00000390424.2
|
T cell receptor alpha variable 2 |
|
chr14_+_22409308 Show fit | 4.89 |
ENST00000390441.2
|
T cell receptor alpha variable 9-2 |
|
chr5_+_156569944 Show fit | 4.81 |
ENST00000521769.1
|
IL2-inducible T-cell kinase |
|
chr14_+_22320634 Show fit | 4.21 |
ENST00000390435.1
|
T cell receptor alpha variable 8-3 |
|
chr12_+_113229737 Show fit | 3.75 |
ENST00000551052.1
ENST00000415485.3 |
rabphilin 3A homolog (mouse) |
|
chr12_+_113229543 Show fit | 3.23 |
ENST00000447659.2
|
rabphilin 3A homolog (mouse) |
|
chr14_+_22788560 Show fit | 3.18 |
ENST00000390468.1
|
T cell receptor alpha variable 41 |
|
chr1_-_160832490 Show fit | 2.97 |
ENST00000322302.7
ENST00000368033.3 |
CD244 molecule, natural killer cell receptor 2B4 |
|
chr1_-_160832642 Show fit | 2.92 |
ENST00000368034.4
|
CD244 molecule, natural killer cell receptor 2B4 |
|
chr12_+_113229452 Show fit | 2.87 |
ENST00000389385.4
|
rabphilin 3A homolog (mouse) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 12.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
2.1 | 8.5 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.0 | 4.9 | GO:0031295 | T cell costimulation(GO:0031295) |
0.3 | 4.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 3.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 3.2 | GO:0007602 | phototransduction(GO:0007602) |
0.9 | 2.8 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) regulation of tolerance induction dependent upon immune response(GO:0002652) negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.7 | 2.6 | GO:0051413 | response to cortisone(GO:0051413) |
0.0 | 2.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 10.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 3.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 3.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 3.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 2.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 2.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 2.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 2.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 2.2 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 12.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 8.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 5.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 4.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 4.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 2.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 2.5 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 2.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 2.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 2.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 2.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 4.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 4.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 2.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |